Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy

(2011) Jørgen Bjerggaard Jensen et al.   EUROPEAN UROLOGY

Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro

(2011) E Noetzel et al.   ONCOGENE

Overexpression of Kpnβ1 and Kpnα2 Importin Proteins in Cancer Derives from Deregulated E2F Activity

(2011) Pauline J. van der Watt et al.   PLoS One

Clinical Significance of Stanniocalcin 2 as a Prognostic Marker in Gastric Cancer

(2010) Takehiko Yokobori et al.   ANNALS OF SURGICAL ONCOLOGY

Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

(2010) Chun-I. Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

(2010) Louis Vermeulen et al.   NATURE CELL BIOLOGY

Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis

(2010) Min Zheng et al.   OBSTETRICS AND GYNECOLOGY

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion

(2010) K. D. Grugan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

(2009) Chie Kudo-Saito et al.   CANCER CELL

Genome-wide expression profile of sporadic gastric cancers with microsatellite instability

(2008) Mariarosaria D’Errico et al.   EUROPEAN JOURNAL OF CANCER

Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

(2008) Oleg Gluz et al.   INTERNATIONAL JOURNAL OF CANCER